Target intelligence / Profile preview

Glycine N-acyltransferase (GLYAT)

Target
GLYAT
Molecular classification
Enzyme, Acyltransferase, Phase II detoxification enzyme
01

Overview

Glycine N-acyltransferase (GLYAT) is a mitochondrial enzyme that catalyzes the conjugation of glycine with acyl-CoA thioesters, predominantly benzoyl-CoA, resulting in the formation of N-acylglycines such as hippuric acid. This reaction is a key step in the phase II detoxification pathway for both endogenous metabolites and xenobiotics, enabling their excretion. GLYAT displays substrate preference for benzoyl-CoA but can conjugate a broad spectrum of acyl-CoAs. Deficiency or genetic variation in GLYAT can impact the metabolism of compounds like benzoic acid and is relevant to disorders such as isovaleric acidemia and risk of toxicity from food preservatives or salicylate drugs.

Other names
Acyl-CoA:glycine N-acyltransferaseGlycine acyltransferaseGlycine-N-acylaseACGNATEC 2.3.1.13
02

Mechanism of action

Detoxification through formation of N-acylglycines, especially conjugating glycine to acyl-CoA thioesters (most notably benzoyl-CoA), facilitating urinary excretion

03

Biological functions

Detoxification of endogenous and exogenous carboxylic acidsConjugation of benzoic acid to hippuric acidFormation of N-acylglycines (especially hippuric acid)
04

Disease associations

Inborn errors of metabolism (e.g., isovaleric acidemia)Potential links to drug or toxin sensitivity (e.g., benzoate overload risk)Defects can impair detoxification of xenobiotics and fatty acids
05

Safety considerations

Reduced GLYAT function can result in accumulation of toxic CoA intermediates and impaired detoxification, which is particularly relevant in susceptible individuals (e.g., with genetic variants or inborn errors of metabolism)
06

Interacting drugs

Benzoic acid

2 more in the full profile.

07

Biomarkers

Hippuric acid (N-benzoylglycine) in urine as a biomarker for enzyme activity and exposure to benzoate or related xenobiotics

Beyond the preview

Go deeper on Glycine N-acyltransferase (GLYAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycine N-acyltransferase (GLYAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call